Orencia abatacept: Pivotal trial data

In a double-blind, placebo-controlled study in 431 RA patients who had an inadequate response to methotrexate (MTX), Orencia significantly reduced DAS28 scores at 6 months

Read the full 258 word article

How to gain access

Continue reading with a
two-week free trial.